ID

38165

Beschreibung

Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01980823

Link

https://clinicaltrials.gov/show/NCT01980823

Stichworte

Versionen (1)
  1. 23.09.19 23.09.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

23. September 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT01980823

Englisch

Eligibility Breast Cancer NCT01980823

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
female subjects with histologically-confirmed operable invasive breast cancer or dcis, who undergo core needle biopsy followed by surgical excision at least 2 weeks after enrollment
Beschreibung

Gender | Invasive carcinoma of breast Operable | DCIS Operable | Core needle biopsy Followed by Excision

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0853879
UMLS CUI [2,2]
C0205188
UMLS CUI [3,1]
C0007124
UMLS CUI [3,2]
C0205188
UMLS CUI [4,1]
C1318309
UMLS CUI [4,2]
C0332283
UMLS CUI [4,3]
C0728940
> 5 mm by imaging/pathology of core to ensure enough pre- and post-treatment tissue for analysis
Beschreibung

Tissue specimen pre treatment Analysis | Tissue specimen post treatment Analysis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1292533
UMLS CUI [1,2]
C2709094
UMLS CUI [1,3]
C0002778
UMLS CUI [2,1]
C1292533
UMLS CUI [2,2]
C2709088
UMLS CUI [2,3]
C0002778
age ≥ 21 years. breast cancer is uncommon in patients less than this age.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
no prior chemotherapy, radiation therapy, or breast resection within 6 months of study entry
Beschreibung

Prior Chemotherapy Absent | Prior radiation therapy Absent | Breast excision Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0279134
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0191848
UMLS CUI [3,2]
C0332197
eastern cooperative oncology group (ecog) performance status 0-1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
signed informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
currently on medication for diabetes or hypercholesterolemia
Beschreibung

Antidiabetics | Hypocholesteremic Agents

Datentyp

boolean

Alias
UMLS CUI [1]
C0935929
UMLS CUI [2]
C0020602
treatment with other investigational drugs within 6 months of study entry
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
strong cyp 3a4 inhibitors (e.g., clarithromycin, hiv protease inhibitors, and itraconazole), given potential interactions with atorvastatin
Beschreibung

CYP3A4 Inhibitors Strong | Clarithromycin | HIV Protease Inhibitors | Itraconazole | Interactions Atorvastatin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3850053
UMLS CUI [1,2]
C0442821
UMLS CUI [2]
C0055856
UMLS CUI [3]
C0162714
UMLS CUI [4]
C0064113
UMLS CUI [5,1]
C0687133
UMLS CUI [5,2]
C0286651
renal impairment with a creatinine > 1.4 mg/dl
Beschreibung

Renal Insufficiency | Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
hepatic impairment: aspartate transaminase (ast)/(sgot), alanine transaminase(alt)/(sgpt) > 2.5 x upper limit of normal range (uln), or total bilirubin > 1.5 x uln (subjects with gilbert's syndrome can have bilirubin of up to 1.5 x uln), or alkaline phosphatase > 2.5 x uln
Beschreibung

Hepatic impairment | Aspartate aminotransferase increased | Alanine aminotransferase increased | Elevated total bilirubin | Gilbert Disease | Alkaline phosphatase raised

Datentyp

boolean

Alias
UMLS CUI [1]
C0948807
UMLS CUI [2]
C0151904
UMLS CUI [3]
C0151905
UMLS CUI [4]
C0741494
UMLS CUI [5]
C0017551
UMLS CUI [6]
C0151849
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT01980823

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Invasive carcinoma of breast Operable | DCIS Operable | Core needle biopsy Followed by Excision
Item
female subjects with histologically-confirmed operable invasive breast cancer or dcis, who undergo core needle biopsy followed by surgical excision at least 2 weeks after enrollment
boolean
C0079399 (UMLS CUI [1])
C0853879 (UMLS CUI [2,1])
C0205188 (UMLS CUI [2,2])
C0007124 (UMLS CUI [3,1])
C0205188 (UMLS CUI [3,2])
C1318309 (UMLS CUI [4,1])
C0332283 (UMLS CUI [4,2])
C0728940 (UMLS CUI [4,3])
Tissue specimen pre treatment Analysis | Tissue specimen post treatment Analysis
Item
> 5 mm by imaging/pathology of core to ensure enough pre- and post-treatment tissue for analysis
boolean
C1292533 (UMLS CUI [1,1])
C2709094 (UMLS CUI [1,2])
C0002778 (UMLS CUI [1,3])
C1292533 (UMLS CUI [2,1])
C2709088 (UMLS CUI [2,2])
C0002778 (UMLS CUI [2,3])
Age
Item
age ≥ 21 years. breast cancer is uncommon in patients less than this age.
boolean
C0001779 (UMLS CUI [1])
Prior Chemotherapy Absent | Prior radiation therapy Absent | Breast excision Absent
Item
no prior chemotherapy, radiation therapy, or breast resection within 6 months of study entry
boolean
C1514457 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0191848 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Antidiabetics | Hypocholesteremic Agents
Item
currently on medication for diabetes or hypercholesterolemia
boolean
C0935929 (UMLS CUI [1])
C0020602 (UMLS CUI [2])
Investigational New Drugs
Item
treatment with other investigational drugs within 6 months of study entry
boolean
C0013230 (UMLS CUI [1])
CYP3A4 Inhibitors Strong | Clarithromycin | HIV Protease Inhibitors | Itraconazole | Interactions Atorvastatin
Item
strong cyp 3a4 inhibitors (e.g., clarithromycin, hiv protease inhibitors, and itraconazole), given potential interactions with atorvastatin
boolean
C3850053 (UMLS CUI [1,1])
C0442821 (UMLS CUI [1,2])
C0055856 (UMLS CUI [2])
C0162714 (UMLS CUI [3])
C0064113 (UMLS CUI [4])
C0687133 (UMLS CUI [5,1])
C0286651 (UMLS CUI [5,2])
Renal Insufficiency | Creatinine measurement, serum
Item
renal impairment with a creatinine > 1.4 mg/dl
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Hepatic impairment | Aspartate aminotransferase increased | Alanine aminotransferase increased | Elevated total bilirubin | Gilbert Disease | Alkaline phosphatase raised
Item
hepatic impairment: aspartate transaminase (ast)/(sgot), alanine transaminase(alt)/(sgpt) > 2.5 x upper limit of normal range (uln), or total bilirubin > 1.5 x uln (subjects with gilbert's syndrome can have bilirubin of up to 1.5 x uln), or alkaline phosphatase > 2.5 x uln
boolean
C0948807 (UMLS CUI [1])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0741494 (UMLS CUI [4])
C0017551 (UMLS CUI [5])
C0151849 (UMLS CUI [6])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video